[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI935092A - D3-vitaminanaloger - Google Patents

D3-vitaminanaloger Download PDF

Info

Publication number
FI935092A
FI935092A FI935092A FI935092A FI935092A FI 935092 A FI935092 A FI 935092A FI 935092 A FI935092 A FI 935092A FI 935092 A FI935092 A FI 935092A FI 935092 A FI935092 A FI 935092A
Authority
FI
Finland
Prior art keywords
hydrogen
vitaminanaloger
diseases
acyl
chem
Prior art date
Application number
FI935092A
Other languages
English (en)
Other versions
FI935092A0 (fi
Inventor
Thomas I Doran
John Arthur Mclane
Masami Okabe
Michelangelo Scalone
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI935092A0 publication Critical patent/FI935092A0/fi
Publication of FI935092A publication Critical patent/FI935092A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI935092A 1992-11-20 1993-11-17 D3-vitaminanaloger FI935092A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97913392A 1992-11-20 1992-11-20

Publications (2)

Publication Number Publication Date
FI935092A0 FI935092A0 (fi) 1993-11-17
FI935092A true FI935092A (fi) 1994-05-21

Family

ID=25526724

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935092A FI935092A (fi) 1992-11-20 1993-11-17 D3-vitaminanaloger

Country Status (25)

Country Link
US (3) US5342833A (fi)
EP (1) EP0599114B1 (fi)
JP (2) JP2502931B2 (fi)
KR (1) KR940011443A (fi)
CN (1) CN1051762C (fi)
AT (1) ATE147728T1 (fi)
AU (1) AU669222B2 (fi)
BR (1) BR9304780A (fi)
CA (1) CA2108848A1 (fi)
CZ (1) CZ284415B6 (fi)
DE (1) DE69307478T2 (fi)
DK (1) DK0599114T3 (fi)
ES (1) ES2097423T3 (fi)
FI (1) FI935092A (fi)
GR (1) GR3022691T3 (fi)
HU (1) HU213609B (fi)
IL (1) IL107614A (fi)
NO (1) NO304022B1 (fi)
NZ (1) NZ250194A (fi)
PH (1) PH30991A (fi)
PL (1) PL176017B1 (fi)
RU (1) RU2126385C1 (fi)
TW (1) TW267161B (fi)
UY (1) UY23678A1 (fi)
ZA (1) ZA938478B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA95906B (en) * 1994-02-07 1996-08-06 Res Developments Foundation Non-viral vector
JPH11514999A (ja) * 1995-10-10 1999-12-21 ストルーブ,マリリン ビタミンdおよびその誘導体による掻痒症治療
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
US5691328A (en) * 1996-02-02 1997-11-25 Clarion Pharmaceuticals Inc. Phosphoethanolamine conjugates of vitamin D compounds
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
DK0884308T3 (da) * 1997-05-02 2003-07-21 Duphar Int Res Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelser
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
JP2017505778A (ja) 2014-01-29 2017-02-23 ヒューメディックス カンパニー,リミテッド ペグ化7−デヒドロコレステロール誘導体
KR101702076B1 (ko) 2015-02-25 2017-02-02 주식회사 휴메딕스 지방산 컨쥬게이션된 7-데하이드로콜레스테롤 유도체

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970676A (en) * 1974-10-29 1976-07-20 The Upjohn Company Novel process and intermediate compounds used is preparation of -Δ5,7- steroid dienes
US4116985A (en) * 1976-07-26 1978-09-26 The Upjohn Company Novel method for preparing cholesta-5,7-diene 3β,25-diol and derivatives thereof
US4360471A (en) * 1981-12-11 1982-11-23 Wisconsin Alumni Research Foundation 23-Dehydro-25-hydroxyvitamin D3
US4456553A (en) * 1982-05-07 1984-06-26 Teijin Limited Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
JPS63264452A (ja) * 1986-10-20 1988-11-01 Sumitomo Pharmaceut Co Ltd フッ素化ビタミンd↓3誘導体
EP0321572B1 (en) * 1987-03-30 1993-06-09 Kuraray Co., Ltd. Pregnane derivatives and process for their preparation
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5218109A (en) * 1988-07-05 1993-06-08 Kuraray Co., Ltd. Steroid compounds
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater
AU6441890A (en) * 1989-09-11 1991-04-08 Wisconsin Alumni Research Foundation Novel use of vitamin d compounds to inhibit replication of the aids virus
EP0441467B1 (de) * 1990-02-06 1994-06-01 Schering Aktiengesellschaft Seitenketten-homologe Vitamin-D-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate, sowie deren Verwendung als Arzneimittel
DE4101953A1 (de) * 1991-01-19 1992-07-23 Schering Ag 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel
DE4105503A1 (de) * 1991-02-19 1992-08-20 Jenapharm Gmbh Ausgangsverbindungen zur herstellung von calcitriol sowie dessen abkoemmlingen, verfahren zur herstellung dieser ausgangsverbindungen sowie zwischenprodukte fuer dieses verfahren
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
DE69213844T2 (de) * 1991-07-05 1997-04-10 Duphar Int Res Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür

Also Published As

Publication number Publication date
NO934197L (no) 1994-05-24
HU213609B (en) 1997-08-28
UY23678A1 (es) 1994-05-20
PL301103A1 (en) 1994-05-30
RU2126385C1 (ru) 1999-02-20
JP2502931B2 (ja) 1996-05-29
US5342833A (en) 1994-08-30
PL176017B1 (pl) 1999-03-31
ES2097423T3 (es) 1997-04-01
NO304022B1 (no) 1998-10-12
DE69307478T2 (de) 1997-05-28
US5393900A (en) 1995-02-28
BR9304780A (pt) 1994-07-05
HU9303227D0 (en) 1994-03-28
KR940011443A (ko) 1994-06-21
TW267161B (fi) 1996-01-01
CA2108848A1 (en) 1994-05-21
ATE147728T1 (de) 1997-02-15
CZ284415B6 (cs) 1998-11-11
GR3022691T3 (en) 1997-05-31
JPH06199777A (ja) 1994-07-19
US5747478A (en) 1998-05-05
CN1090573A (zh) 1994-08-10
IL107614A (en) 1999-09-22
CN1051762C (zh) 2000-04-26
IL107614A0 (en) 1994-02-27
JPH08109191A (ja) 1996-04-30
AU5069793A (en) 1994-06-02
EP0599114A1 (en) 1994-06-01
DK0599114T3 (da) 1997-04-14
NO934197D0 (no) 1993-11-19
FI935092A0 (fi) 1993-11-17
ZA938478B (en) 1994-05-20
NZ250194A (en) 1996-01-26
AU669222B2 (en) 1996-05-30
PH30991A (en) 1997-12-23
HUT66022A (en) 1994-08-29
DE69307478D1 (de) 1997-02-27
CZ248993A3 (en) 1994-06-15
EP0599114B1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
TW269678B (fi)
ATE74508T1 (de) Azithromycin und seine derivate als antiprotozoenmittel.
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
ATE67185T1 (de) Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel.
ATE141914T1 (de) Fluorierte analoge vitamins d3
TW222638B (fi)
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
FI935092A0 (fi) D3-vitaminanaloger
NO903148L (no) Hemoreguleringspeptider.
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
UA26077C2 (uk) Аплікаційhий матеріал лікувальhо-профілактичhого призhачеhhя
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis